Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Bioorg Chem ; 124: 105813, 2022 07.
Article in English | MEDLINE | ID: mdl-35447405

ABSTRACT

A series of dihydrotriazine derivatives bearing 5-aryloxypyrazole moieties were designed, and their anticancer activities against three human cancer cell lines (SGC-7901, HepG-2 and MCF-7) and one non-cancer cell line (LO2) were explored using the MTT assay in vitro. Most of the compounds exhibited potent antiproliferative activities against the three cancer cell lines, with compound 10e (IC50 = 2.12 µM) exhibiting the most potent antiproliferative activity against HepG-2 cells. Interestingly, autophagy was observed in the 10e-treated HepG-2 cells. Compound 10e also increased reactive oxygen species (ROS) levels and resulted in marked HepG-2 cells apoptosis. Further studies revealed that compound 10e could enhance the expression of Cl-PARP, Cl-caspase-3, and Cl-caspase-9. In addition, 10e triggered the formation of autophagosomes by promoting LC3-II and Beclin-1 expression. These results might be useful for exploring and developing dihydrotriazine derivatives as novel anticancer agents.


Subject(s)
Antineoplastic Agents , Neoplasms , Antineoplastic Agents/pharmacology , Apoptosis , Autophagy , Cell Line, Tumor , Cell Proliferation , Drug Screening Assays, Antitumor , Humans , Reactive Oxygen Species/metabolism , Structure-Activity Relationship
2.
Anal Bioanal Chem ; 409(7): 1895-1904, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28012110

ABSTRACT

Highly efficient extraction of peptides from serum is critical for finding serum biomarkers using mass spectrometry, which still remains a great challenge. Currently, a bottom-up proteomics approach has been applied to discover serum biomarkers. However, the approach was labor intensive, time and cost consuming, and cannot meet the requirements for clinical application. In this work, Fe3O4/C@MIL-100 composites were synthesized to efficiently capture peptides from microwave-assisted formic acid digests of BSA and human serum prior to MALDI-TOF MS analysis. Fe3O4/C@MIL-100 composites exhibited size-selective adsorption performance, thus providing a rapid and convenient approach to enrich low-abundance peptides. Notably, the peptides' mass fingerprinting of serum digestions between type 2 diabetes mellitus (T2DM) and healthy persons were distinguishable, which indicated the potential ability of this technique for T2DM diagnosis and rapid biomarker discovery. Graphical Abstract Efficient extraction and identification of serum biomarkers using Fe3O4/C@MIL-100 composites from acid hydrolysate.


Subject(s)
Biomarkers/blood , Ferrosoferric Oxide/chemistry , Magnetics , Diabetes Mellitus, Type 2/blood , Humans , Microscopy, Electron, Scanning , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
3.
Anal Chim Acta ; 868: 36-44, 2015 Apr 08.
Article in English | MEDLINE | ID: mdl-25813232

ABSTRACT

Rapid and efficient characterization and identification of pathogens at the strain level is of key importance for epidemiologic investigations, which still remains a challenge. In this work, solvothermically Fe3O4-COOH@MIL-101 composites were fabricated by in situ crystallization approach. The composites combine the excellent properties of both chromium (III) terephthalate (MIL-101) and carboxylic-functionalized magnetite (Fe3O4-COOH) particles and possess the efficient peptides/proteins enrichment properties and magnetic responsiveness. Fe3O4-COOH@MIL-101 composites as magnetic solid phase extraction materials were used to increase the discriminatory power of MALDI-TOF MS profiles. BSA tryptic peptides at a low concentration of 0.25 fmol µL(-1) could be detected by MALDI-TOF MS. In addition, Fe3O4-COOH@MIL-101 composites were successfully applied in the selective enrichment of the protein biomarkers from bacterial cell lysates and discrimination of Escherichia coli at the strain level. This work provides the possibility for wide applications of magnetic MOFs to discriminate pathogens below the species level.


Subject(s)
Escherichia coli/isolation & purification , Magnets/chemistry , Animals , Bacterial Proteins/chemistry , Biomarkers/chemistry , Cattle , Chemistry Techniques, Synthetic , Escherichia coli/chemistry , Ferrosoferric Oxide/chemical synthesis , Ferrosoferric Oxide/chemistry , Peptides/chemistry , Species Specificity
4.
J Microbiol ; 52(4): 324-32, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24535741

ABSTRACT

Antifungal lipopeptide produced by Bacillus sp. BH072 was extracted from fermentation liquor and determined as iturin A by liquid chromatography-mass spectrometry (LC-MS). For industrial-scale production, the yield of iturin A was improved by optimizing medium components and fermentation conditions. A one-factor test was conducted; fermentation conditions were then optimized by response surface methodology (RSM) to obtain the following: temperature, 29.5°C; pH 6.45; inoculation quantity, 6.7%; loading volume, 100 ml (in 500 ml flasks); and rotary speed, 150 rpm. Under these conditions, the mass concentration of iturin A was increased from 45.30 mg/ml to 47.87 mg/ml. The following components of the medium were determined: carbon sources (glucose, fructose, sucrose, xylose, rhamnose, and soluble starch); nitrogen sources (peptone, soybean meal, NH4Cl, urea, and ammonium citrate); and metal ions (Zn(2+), Fe(3+), Mg(2+), Mn(2+), Ca(2+), and K(+)). The effects of these components on iturin A production were observed in LB medium. We selected sucrose, soybean meal, and Mg(2+) for RSM to optimize the conditions because of several advantages, including maximum iturin A production, high antifungal activity, and low cost. The optimum concentrations of these components were 0.98% sucrose, 0.94% soybean meal, and 0.93% Mg(2+). After iturin A production was optimized by RSM, the mass concentration reached 52.21 mg/ml. The antifungal specific activity was enhanced from 350.11 AU/mg to 513.92 AU/mg, which was 46.8% higher than the previous result. The present study provides an important experimental basis for the industrial-scale production of iturin A and the agricultural applications of Bacillus sp. BH072.


Subject(s)
Antifungal Agents/metabolism , Bacillus/growth & development , Bacillus/metabolism , Lipopeptides/metabolism , Peptides, Cyclic/metabolism , Bacillus/genetics , Biotechnology/methods , Chromatography, Liquid , Culture Media/chemistry , Fermentation , Hydrogen-Ion Concentration , Lipopeptides/genetics , Mass Spectrometry , Peptides, Cyclic/genetics , Technology, Pharmaceutical/methods , Temperature
5.
Microbiol Res ; 168(9): 598-606, 2013 Nov 07.
Article in English | MEDLINE | ID: mdl-23545354

ABSTRACT

A bacterial strain BH072 isolated from a honey sample showed antifungal activity against mold. Based on morphological, biochemical, physiological tests, and analysis of 16S rDNA sequence, the strain was identified to be a new subspecies of Bacillus sp. It had a broad spectrum of antifungal activity against various mold, such as Aspergillus niger, Pythium, and Botrytis cinerea. Six pairs of antifungal genes primers were designed and synthesized, and ituA, hag, tasA genes were detected by PCR analysis. The remarkable antifungal activity could be associated with the co-production of these three peptides. One of them was purified by 30-40% ammonium sulfate precipitation, Sephadex G-75 gel filtration and anion exchange chromatography on D201 resin. The purified peptide was estimated to be 35.615 kDa and identified to be flagellin by micrOTOF-Q II. By using methanol extraction, another substance was isolated from fermentation liquor, and determined to be iturin with liquid chromatography-mass spectrometry (LC-MS) method. The third possible peptide encoded by tasA was not isolated in this study. The culture liquor displayed antifungal activity in a wide pH range (5.0-9.0) and at 40-100°C. The result of the present work suggested that Bacillus BH072 might be a bio-control bacterium of research value.


Subject(s)
Antifungal Agents/pharmacology , Ascomycota/drug effects , Aspergillus niger/drug effects , Bacillus/metabolism , Honey/microbiology , Peptides/pharmacology , Pythium/drug effects , Antifungal Agents/chemistry , Antifungal Agents/isolation & purification , Bacillus/classification , Bacillus/genetics , Bacillus/isolation & purification , Bacterial Typing Techniques , Chromatography, Gel , Chromatography, Ion Exchange , Cluster Analysis , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , DNA, Ribosomal/chemistry , DNA, Ribosomal/genetics , Mass Spectrometry , Molecular Weight , Peptides/chemistry , Peptides/isolation & purification , Phylogeny , RNA, Ribosomal, 16S/genetics , Sequence Analysis, DNA
6.
Appl Biochem Biotechnol ; 166(6): 1388-400, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22246730

ABSTRACT

To investigate the effect of pH and temperature on the cell growth and bacteriocin production of Pediococcus acidilactici PA003, a lactic acid bacterium isolated from traditionally fermented cabbage, the kinetic behaviour of P. acidilactici PA003 was simulated in vitro during laboratory fermentations by making use of MRS broth. Firstly, primary models were developed for cell growth, glucose consumption, lactic acid and bacteriocin production for a given set of environmental conditions. Based on primary models, further study was undertaken to fit secondary models to describe the influence of temperature and pH on microbial behaviour. The models were validated successfully for all components. The results from the cell yield coefficient for lactic acid production reflected the homofermentative nature of P. acidilactici PA003. Both cell growth and bacteriocin production were very much influenced by changes in temperature and pH. The optimal condition for specific growth rate and biomass concentration was almost the same at pH 6.5 and 35 °C. At 35 °C and pH 6.1, the maximal bacteriocin activity was also achieved. The kinetic models provide useful tools for elucidating the mechanisms of temperature and pH on the kinetic behaviour of P. acidilactici PA003. The information obtained in this paper may be very useful for the selection of suitable starter cultures for a particular fermentation process and is a first step in the optimization of food fermentation processes and technology as well.


Subject(s)
Bacteriocins/biosynthesis , Pediococcus/growth & development , Temperature , Bacteriological Techniques , Brassica/metabolism , Brassica/microbiology , Culture Media/metabolism , Fermentation , Glucose/metabolism , Hydrogen-Ion Concentration , Lactic Acid/metabolism , Listeria monocytogenes/growth & development , Models, Biological , Pediococcus/isolation & purification , Pediococcus/metabolism
7.
J Zhejiang Univ Sci B ; 12(1): 65-71, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21194188

ABSTRACT

Two heterologous expression systems using thioredoxin (trxA) as a gene fusion part in Escherichia coli were developed to produce recombinant pediocin PA-1. Pediocin PA-1 structural gene pedA was isolated from Pediococcus acidilactici PA003 by the method of polymerase chain reaction (PCR), then cloned into vector pET32a(+), and expressed as thioredoxin-PedA fusion protein in the host strain E. coli BL21 (DE3). The fusion protein was in the form of inclusion body and was refolded before purification by nickel-iminodiacetic acid (Ni-IDA) agarose resin column. Biological activity of recombinant pediocin PA-1 was analyzed after cleavage of the fusion protein by enterokinase. Agar diffusion test revealed that 512-arbitrary unit (AU) recombinant pediocin PA-1 was obtained from 1 ml culture medium of E. coli (pPA003PED1) using Listeria monocytogenes as the indicator strain. Thioredoxin-PedA fusion gene was further cloned into pET20b(+). Thioredoxin-PedA fusion protein was detected in both the periplasmic and cytoplasmic spaces. The recombinant pediocin PA-1 from the soluble fraction attained 384 AU from 1 ml culture medium of E. coli (pPA003PED2). Therefore, biologically active pediocin PA-1 could be obtained by these two hybrid gene expression methods.


Subject(s)
Bacteriocins/biosynthesis , Bacteriocins/genetics , Escherichia coli/genetics , Escherichia coli/metabolism , Gene Fusion , Genes, Bacterial , Bacteriocins/pharmacology , Base Sequence , Cloning, Molecular , DNA Primers/genetics , Enteropeptidase , Escherichia coli Proteins/biosynthesis , Escherichia coli Proteins/genetics , Gene Expression , Inclusion Bodies/metabolism , Listeria monocytogenes/drug effects , Pediocins , Pediococcus/genetics , Plasmids/genetics , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/pharmacology , Thioredoxins/biosynthesis , Thioredoxins/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...